A dose-dependent reduction in the total leukocyte number at three doses tested by up to 62%
200, 400, and 600 mg/kg
Swiss albino mice
Acetic acid-induced vascular permeability
Attenuation of vasodilation and decreased vascular permeability in mice at 400 or 600 mg/kg by 63 and 58%, respectively
200 and 400 mg/kg
Antinociceptive activity by hot plate test
A dose-dependent increase in response latency using 200 and 400 mg/kg by up to 200%
200 and 400 mg/kg
Antinociceptive activity by acetic acid-induced abdominal writhing
94% reduction of the writhing response using 400 mg/kg
200 and 400 mg/kg
Male Wistar rats
Heat hyperalgesia
Restoration of heat response latency when measured at day 14 post chronic constriction injury (CCI) by about 160 and 200% using 200 and 400 mg/kg, respectively
Increased the withdrawal time of injured hind paw by 8.4- and 6-folds after 7 and 14 days, respectively
Acetone drop test (paw cold allodynia)
Decreased cold allodynia score by about 16- and 10-folds after 7 and 14 days using 200 and 400 mg/kg, respectively
Paint-brush test (mechanical dynamic allodynia)
Attenuated the dynamic allodynia score when assessed at day 7 by up to 1.75-folds Normalization of dynamic response score by 400 mg/kg dose level when measured at day 14 post surgery
Aqueous extract
2000 and 5000 mg/kg
Albino Wistar rats
Acute toxicity study for 14 days
No mortality or signs of toxicity and no significant differences in body weight, food consumption, and absolute organ weights between controls and treated animals
No influence on the levels of AST and ALT A significant reduction in phosphatase alkaline levels by up to 35% using 400 mg/kg No effect on the levels of urea and creatinine
Increased the plasma antioxidant levels by 3-folds (22% of inhibition) using 800 mg/kg
Increased the iron reducing ability (908 μM FeSO4 eq/mL) using 800 mg/kg by 2-folds compared to the nontreated group (405 μM FeSO4 eq/mL) Improved CAT activity by 24 to 86% using 200 to 800 mg/kg Increased GSH levels in mice treated with 400 and 800 mg/kg (34 to 45 nmol/mL) compared to those of the nontreated group (30 nmol/mL) Decreased the MDA levels in the plasma of treated groups at 200 and 400 mg/kg by 50 and 63%, respectively
Tunisia
Aerial part
EO
180 mg/kg per day dissolved in normal saline
Sprague Dawley rats
Body weight gain, toxicity, and mortality
Body weight gain, no mortality, and no sign of toxicity after 15 days of experiment
No effect on sperm’s morphology, counts, and mobility
Sperm count and motility
Sperm viability
Increased the sperm’s viability by up to 46%
Histopathological studies
Improvement in morphological abnormalities (amorphous head, hookless head, doublet heads, compact head tail with a cytoplasmic droplet, irregular tail, and coiled tail) of sperms
DNA fragmentation analysis using gel electrophoresis
Protection against H2O2-induced DNA fragmentation in testis
Lipid peroxidation
Reduction of the levels of MDA in testicular cells induced by H2O2 at 1 mmol/L
Assessment of nonenzymatic antioxidants
Prevention of the H2O2-induced alterations in GSH level
Protein estimation
Increase in total protein
180 mg/kg per day
Sprague Dawley rats
Hepatic and renal functional marker enzymes
Attenuation of the increase in AST and reduction in urea and creatinine levels in H2O2-treated group
Recovered the levels of CAT (up to 150% increase), SOD (up to 233% increase), GST (up to 15.7% increase) and GPx (up to 71.4% increase) activities, and GSH (up to 98% increase)
Histopathological examination
No histopathological changes in the liver and kidney Alleviation of the injuries in the glomeruli and proximal tubules (77.7% reduction in damage score)
Body and organ weights
Prevention of H2O2-induced liver, kidney, and weight loss
54, 117, and 180 mL/kg
Adult male and female Wistar rats
Histology of gastric lesions
Lesions inhibition mainly at doses of 180 mg/kg for male rats (88%) and between 117 and 180 mg/kg for female rats (96.25 and 98.85%)